Even before the COVID crisis, excessive use and misuse of lifesaving antibiotics had contributed to the emergence of resistant strains of disease-causing organisms. This has rendered many of the most powerful treatments in modern medicine ineffective. It's estimated that drug-resistant infections caused more than 1.2 million deaths in 2019.
Protein Sciences in Meriden suffers setback in COVID-19 vaccine development. Author: Matt Caron Updated: 4:28 PM EST December 11, 2020
HARTFORD, Conn. Connecticut could get its first shipments of COVID vaccine this weekend and we are learning new information about the intake process, and rollout of the first shots. Plus, there is news that a vaccine company with Connecticut ties has suffered a setback in their vaccine development.
Protein Sciences here in Meriden is a Sanofi company. FOX61 broke the news that a COVID vaccine was being researched and developed there. We learned on Friday that their vaccine will be delayed.
Back in September, Clem Lewin of Sanofi told FOX61, We are on track to start our phase 3 trial in December and Produce 100-million doses by early next year.